Natural Product (NP) Details
General Information of the NP (ID: NP6300) | |||||
---|---|---|---|---|---|
Name |
Sinomenine
|
||||
Synonyms |
Sinomenine; 115-53-7; Cucoline; Kukoline; Coculine; Sabianine A; CCRIS 1550; UNII-63LT81K70N; CHEBI:9163; CHEMBL248095; 63LT81K70N; morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, (9alpha,13alpha,14alpha)-; SR-05000002170; EINECS 204-094-6; BRN 0095280; Sinomenine,(S); Sinomenine (Cucoline); (9alpha,13alpha,14alpha)-4-Hydroxy-3,7-dimethoxy-17-methyl-7,8-didehydromorphinan-6-one hydrochloride; Spectrum2_001242; Spectrum3_001134; Spectrum4_001981; Spectrum5_001621; UPCMLD-DP085; 7,8-Didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-9-alpha,13-alpha,14-alpha-morphinan-6-one; BSPBio_002627; KBioGR_002508; 5-21-13-00516 (Beilstein Handbook Reference); SCHEMBL363812; SPECTRUM1505253; SPBio_001144; 4-Hydroxy-3,7-dimethoxy-17-methyl-7,8-didehydromorphinan-6-one; NP51; UPCMLD-DP085:001; BCBcMAP01_000195; KBio3_002127; DTXSID00871595; BDBM224031; ALBB-020908; BCP20032; ZINC1280591; BDBM50241298; CCG-39100; NSC785175; s2359; AKOS000265568; AKOS015960539; AKOS016023715; AC-8025; NSC-785175; 9-alpha,13-alpha,14-alpha-Morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-; SMP1_000273; NCGC00161641-01; NCGC00161641-02; NCGC00161641-04; NCGC00161641-05; HY-15122; O600; Sinomenine 100 microg/mL in Acetonitrile; CS-0003778; SW219295-1; C09643; 115S537; Sinomenine, 0.3 mol chloroform of crystallization; Q7524904; SR-05000002170-2; SR-05000002170-3; BRD-K83459933-001-02-1; 3-(4-Fluorophenyl)-3-(toluene-4-sulfonylamino)-propionicacid; 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methylmorphinan-6-one; morphinan-6-one, 7,8-didehydro-4-hydroxy-3,7-dimethoxy-17-methyl-, (9alpha,13alpha,14alpha)-, hydrochloride
Click to Show/Hide
|
||||
Species Origin | Sinomenium ... | Click to Show/Hide | |||
Sinomenium | |||||
Disease | Rheumatoid arthritis [ICD-11: FA20] | Discontinued in Phase 2 | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C19H23NO4
|
||||
PubChem CID | |||||
Canonical SMILES |
CN1CCC23CC(=O)C(=CC2C1CC4=C3C(=C(C=C4)OC)O)OC
|
||||
InChI |
1S/C19H23NO4/c1-20-7-6-19-10-14(21)16(24-3)9-12(19)13(20)8-11-4-5-15(23-2)18(22)17(11)19/h4-5,9,12-13,22H,6-8,10H2,1-3H3/t12-,13+,19-/m1/s1
|
||||
InChIKey |
INYYVPJSBIVGPH-QHRIQVFBSA-N
|
||||
CAS Number |
CAS 115-53-7
|
||||
ChEBI ID | |||||
Herb ID | |||||
SymMap ID | |||||
TCMSP ID | |||||
TTD Drug ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
Methotrexate | Leukaemia | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Molecule(s)
Regulation |
Down-regulation | Expression | IL6 | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | MMP-9 | Molecule Info |
Pathway MAP
|
||
In-vivo Model | Arthritis was induced by immunizing with CII in female Srague-Dawley rats. | |||||
Experimental
Result(s) |
SIN and MTX have additive effects, decreasing inflammation and joint damage in CIA rats by modulating osteoclast-related cytokines. These results are indicative of the combined effect of SIN and MTX for anti-arthritic treatment in RA. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | NADPH oxidase (NOX) | Molecule Info | [3] | |
KEGG Pathway | HIF-1 signaling pathway | Click to Show/Hide | ||
2 | Phagosome | |||
3 | Osteoclast differentiation | |||
4 | Leukocyte transendothelial migration | |||
Pathway Interaction Database | RAC1 signaling pathway | Click to Show/Hide | ||
WikiPathways | Vitamin D Receptor Pathway | Click to Show/Hide | ||
2 | TNF alpha Signaling Pathway |

